These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20111820)

  • 1. [Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C].
    Martínez AI; Domínguez A; Oviedo M; Minguell S; Jansà JM; Codina G; Vázquez JA;
    Rev Esp Salud Publica; 2009; 83(5):725-35. PubMed ID: 20111820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.
    Mattheus W; Hanquet G; Collard JM; Vanhoof R; Bertrand S
    PLoS One; 2015; 10(10):e0139615. PubMed ID: 26425857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decline of the incidence of meningococcal disease in Barcelona between 1988 and 2015: the influence of the vaccine against serogroup C.
    Manzanares-Laya S; Parés-Badell O; Gorrindo P; Simón P; Ros M; de Andrés A; López Segura N; Brió Sanagustín S; Vilella A; Rodrigo Gonzalo de Liria C; Orcau À; Caylà JA
    Med Clin (Barc); 2018 Nov; 151(10):390-396. PubMed ID: 29503027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba.
    Ochoa-Azze RF; García-Imía L; Vérez-Bencomo V
    MEDICC Rev; 2018 Jul; 20(3):22-29. PubMed ID: 31242158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.
    Tauil Mde C; Carvalho CS; Vieira AC; Waldman EA
    Braz J Infect Dis; 2014; 18(4):379-86. PubMed ID: 24698710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.
    Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R
    Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.
    de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G
    Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C.
    Fernández S; Arreaza L; Santiago I; Malvar A; Berrón S; Vazquez JA; Hervada X
    J Med Microbiol; 2003 Jan; 52(Pt 1):75-77. PubMed ID: 12488569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
    Mooney JD; Christie P; Robertson C; Clarke SC
    Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780.
    Azevedo AC; Franco NEC; de Carvalho Rocha MR; Andrade C; Torres MC; de Filippis I
    Infect Genet Evol; 2020 Mar; 78():104079. PubMed ID: 31669441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy.
    Pascucci MG; Di Gregori V; Frasca G; Rucci P; Finarelli AC; Moschella L; Borrini BM; Cavrini F; Liguori G; Sambri V; Bonanni P; Fantini MP
    Hum Vaccin Immunother; 2014; 10(3):671-6. PubMed ID: 24384537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.
    De Wals P; Deceuninck G; Boulianne N; De Serres G
    JAMA; 2004 Nov; 292(20):2491-4. PubMed ID: 15562128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term impacts of MenC vaccination campaign in the Salvador, Brazil metropolitan region: A comparison of pre- and post-vaccine periods.
    Monalisa Mendes Dantas Sales N; Azevedo J; Teles Bastos Ribeiro M; Fonseca de Freitas H; Pedreira da Silva Filho H; Machado Cordeiro S; Galvão Reis M; Neves Reis J
    Vaccine; 2020 Sep; 38(40):6267-6273. PubMed ID: 32741673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.